Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Enrolling by invitation

Conditions studied: Type 2 Diabetes Mellitus (T2DM), Type2Diabetes, Diabetes Mellitus, Type 2, Type 2 Diabetes, Diabetes

In brief

This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.

Key facts

Study ID

NCT07197775

Run by

Endogenex, Inc.

People needed

500

Starts

2026-03-11

Expected to finish

2032-05-01

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes
• Have been treated with the Endogenex System
• Consented to participate in the Endogenex PULSE Registry

You may not qualify if…

• Unwilling or unable to attend study visits
• Unwilling or unable to provide medical records to study sites

Where it is running

• Care Access — Quincy, Massachusetts, United States
• Care Access — Raleigh, North Carolina, United States
• Care Access — Houston, Texas, United States
• St Vincent's Hospital Melbourne — Fitzroy, Victoria, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.